Vincerx PharmaVINC
13F holders, Q2 2025 (June 30)1holders −13
1new positions
15sold out
$0.04avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Vincerx Pharma Inc. (VINC) in their 13F filings, down 13 from Q1 2025. 1 opened new positions and 15 sold out. The largest holder was Bank & Trust Co ($2).
- Company
- Vincerx Pharma Inc.
- CUSIP
- 92731L304
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2 |
| Exits | 15 | $117K |
All 13F filers, Q1 2025 → Q2 2025: 50 shares bought and 220,626 shares sold, net −220,576 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Bank & Trust Co | 0.00% | New | 50 | $2 |
"% of holder's portfolio" is VINC's weight in each manager's 13F, not the share of Vincerx Pharma Inc. the manager owns.